Abcam, ab249261, Anti-Glyt2 antibody [EPR10748] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal Glyt2 antibody. Carrier free. Suitable for WB and reacts with Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR10748,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Human,
Applications:WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab249261 is the carrier-free version of
ab156022
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The glycine transporter 2 often referred to as GlyT2 plays an important role mechanically. GlyT2 is responsible for the reuptake of glycine a neurotransmitter from the synaptic cleft back into presynaptic neurons. It is a membrane-bound protein with an approximate molecular mass of 85 kDa. GlyT2 is mostly expressed in the spinal cord and brainstem where it facilitates glycine neurotransmission essential for inhibitory signaling in the central nervous system.
Biological function summary
GlyT2 functions to maintain glycine homeostasis which is important for regulating inhibitory synaptic transmission. GlyT2 operates as part of a larger protein complex that efficiently recycles glycine into neurons which is essential for synaptic vesicle refilling. This recycling mechanism ensures a sufficient supply of glycine in synaptic vesicles contributing to the modulation of neuronal excitability and prevention of excessive excitatory neurotransmission.
Pathways
GlyT2 actively participates in the glycinergic synapse pathway which controls inhibitory neurotransmission. It complements the function of glycine receptors by ensuring sustained glycine availability. Related proteins involved in this pathway include GlyT1 another transporter which works alongside GlyT2 in glycine regulation. Additionally the function of GlyT2 is closely tied to the neurotransmitter release cycle pathway which manages synaptic neurotransmitter levels and synaptic signaling fidelity.
GlyT2 is linked to certain neurological conditions due to its role in regulating glycine levels. Hyperekplexia a genetic disorder characterized by exaggerated startle responses has been associated with mutations in the GlyT2 gene. Additionally GlyT2 might play a part in pain disorders where disrupted glycinergic transmission contributes to pathophysiology. In these conditions altered GlyT2 function impacts the balance of inhibitory and excitatory signals vital for normal sensory processing with GlyT2 interacting with proteins such as inhibitory glycine receptor alpha1 in these disorders.